Caris Life Sciences Inc.

NASDAQ: CAI · Real-Time Price · USD
38.22
-0.26 (-0.68%)
At close: Aug 26, 2025, 12:10 PM

Caris Life Sciences Revenue

Caris Life Sciences reported an annual revenue of $412.26M, reflecting a 34.67% growth. For the quarter ending June 30, 2025, Caris Life Sciences generated $181.4M in revenue.
Revenue (ttm)
412.26M
Revenue Growth
34.67%
Price / Sales Ratio
17.3
Revenue / Employee
233.05K
Employees
1,769
Market Cap
10.75B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 412.26M +34.67%
Dec 31, 2023 306.13M +18.43%
Dec 31, 2022 258.49M -12.08%
Dec 31, 2020 294.01M -29.42%
Dec 31, 2019 416.54M -3.60%
Dec 31, 2018 432.1M +24.03%
Dec 31, 2017 348.39M +18.36%
Dec 31, 2016 294.35M +17.90%
Dec 31, 2015 249.67M +9.70%
Dec 31, 2014 227.59M +7.15%
Dec 31, 2013 212.41M +22.12%
Dec 31, 2012 173.93M +38.36%
Dec 31, 2011 125.71M +61.37%
Dec 31, 2010 77.9M +19.36%
Dec 31, 2009 65.26M -21.51%
Dec 31, 2008 83.14M +28.17%
Dec 31, 2007 64.87M +248.57%
Dec 31, 2006 18.61M -69.78%
Dec 31, 2005 61.59M -7.65%
Dec 31, 2004 66.69M +38.69%
Dec 31, 2003 48.08M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.